This contract opportunity involves the establishment of non-exclusive discount agreements for finished medicines containing the active ingredients Tramadol and Paracetamol (ATC: N02AJ13) under an 'open-house model'. All eligible and interested pharmaceutical companies or consortia are invited to ent
400 days left to bid. Opened 10 months ago, deadline 29 Jun 2027.
This contract opportunity involves the establishment of non-exclusive discount agreements for finished medications containing the active ingredient Timolol (ATC: S01ED01) under an 'open-house model'. All eligible and interested pharmaceutical companies or consortia are invited to enter into or join
This publication is about entering into non-exclusive discount contracts according to § 130a Abs. 8 SGB V for finished medicines containing the active ingredient Abaloparatide (ATC: H05AA04) as part of an "open-house model". Under uniform contract conditions and a standardized access procedure, all
This contract opportunity involves the establishment of non-exclusive discount agreements for finished pharmaceuticals containing the active ingredient Rivaroxaban (ATC: B01AF01 - in all strengths except 2.5 mg per divided oral dosage form) under an 'open-house model'. All eligible and interested ph
This contract involves the delivery of natural gas, including network usage, to the buyer's facilities starting from January 1, 2026, at 6:00 AM. Suppliers are invited to provide proposals for the supply of natural gas to AOK Sachsen-Anhalt. The deadline for submissions is July 22, 2025. For more de
Procurement of medical-grade surgical consumables to support operating theatre operations and patient care delivery.
Supply of orthopedic theatre implants and consumable materials under the Total Orthopaedic Solutions 3 Framework agreement.
Re-procurement of ophthalmic surgical consumables including IOLs, phacoemulsification, and vitreoretinal supplies for continued patient care delivery.
NHS trust seeking lymphoedema garment and accessory suppliers for a 3-year contract starting April 2027, with market engagement event on 16 June 2026.
